Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin 1 pseudogene is a noncoding genomic sequence resembling the functional *dynamin 1* gene (DNM1), which encodes a GTPase involved in vesicle trafficking and endocytosis. As a pseudogene, ENSG00000273512 does not typically produce a functional protein product. Pseudogenes, traditionally considered nonfunctional genomic elements, can sometimes be transcribed and influence gene regulation—such as acting as sources of regulatory RNAs or as microRNA decoys—but are broadly not considered druggable targets or relevant to receptor-based pharmacology[4]. Most pseudogenes do not contribute directly to normal cellular functions or disease, although exceptions exist for individual loci. If you are seeking structured information for informatics or pharmacology, this entry would typically be excluded from target lists as it is nonfunctional and not therapeutically actionable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin 1 pseudogene.